5 Key Takeaways

• 1

  A routine invasive strategy did not reduce cardiovascular death or nonfatal myocardial infarction in frail patients aged 75 and older with NSTEMI.

• 2

  Invasive management showed a hazard ratio of 1.21 for the primary outcome among frail patients, indicating worse outcomes compared to conservative care.

• 3

  The study found no significant benefits of invasive strategies in frail patients, contrasting with the overall SENIOR-RITA trial population.

• 4

  Higher frailty levels correlated with increased relative disadvantage from invasive management, suggesting potential harm in this subgroup.

• 5

  The findings emphasize the need to assess frailty severity when making treatment decisions for older patients with non-ST-elevation myocardial infarction.